YK BIOVENTURES OPPORTUNITIES GP I, LLC sold 31.4% of their position (5.96M shares) of CERO THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market sale worth $400.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/13/2024ACC: 0001415889-24-029371
→
10% Owner
Since Sep 2024
-5.96M
Net shares
Net seller
$400.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
5.96M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−1.34M
Price / share
$0.08
Trade value
$107.50K
% of position
7.1%
12/11/2024
18.96M→17.62M
Common Stock
Indirect
Shares
−1.61M
Price / share
$0.07
Trade value
$113.02K
% of position
9.2%
12/12/2024
17.62M→16M
Common Stock
Indirect
Shares
−3M
Price / share
$0.06
Trade value
$179.93K
% of position
18.7%
12/13/2024
16M→13.01M
Total
Net shares
−5.96M
Net value
-$400.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/11/2024 | S · Sale | −1.34M | $0.08 | $107.50K | 7.1% | 18.96M | 17.62M |
| Common Stock Indirect | 12/12/2024 | S · Sale | −1.61M | $0.07 | $113.02K | 9.2% | 17.62M | 16M |
| Common Stock Indirect | 12/13/2024 | S · Sale | −3M | $0.06 | $179.93K | 18.7% | 16M | 13.01M |
| Total | −5.96M | -$400.46K | ||||||
Derivative Transactions0
No derivative transactions reported